2nd Quarter - Report — ARTHRITIS FOUNDATION for ARTHRITIS FOUNDATION (2024)

Firm

ARTHRITIS FOUNDATION

Client

ARTHRITIS FOUNDATION

Income

—

Expenses

$75,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

out-of-pocket costs, drug prices, utilization management, prior authorization, step therapy, clinical trial diversity, COVID-19 therapeutics, pharmacist scope of practice, telehealth extensions , association health plans, self-insurance protections, short-term limited duration insurance plans -HR 830/S 1357,HELP Copays Act -HR 2630/ S. 652, Safe Step Act -S 1339, Pharmacy Benefit Manager Reform Act -HR 1770, the Equitable Community Access to Pharmacist Services Act -HR 824, the Telehealth Benefit Expansion for Workers Act -Accelerating Kid's Access to Care Act -Reducing Drug Prices for Seniors Act

Lobbyist	Covered position, as disclosed
ALISA VIDULICH CASAVANT	Policy Director
CHARLES HUSSER New	Federal Affairs Manager
ANNA HYDE	Vice President, Advocacy and Access

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); SENATE

Bills named: H.R. 1770 (118th), H.R. 830 (118th), H.R. 2630 (118th), H.R. 824 (118th), S. 652 (118th)

Health Issues HCR

-HR 830 / S 1357, HELP Copays Act -HR 2630 / S 652, Safe Step Act -S 1339, Pharmacy Benefit Manager Reform Act -H.R. 1770, the Equitable Community Access to Pharmacist Services Act -HR 824, the Telehealth Benefit Expansion for Workers Act -Accelerating Kids Access to Care Act - S. 127 Pharmacy Benefit Manager Transparency Act of 2023 - S. 1339 Pharmacy Benefit Manager Reform Act - H.R. 4507 Transparency in Coverage Act of 2023 - H.R. 4822 Health Care Price Transparency Act of 2023 - H.R. 3561 PATIENT Act of 2023 -H.R. 5378 - The Lower Costs, More Transparency Act - H.R. 2761 SPARC Act, Specialty Physicians Advancing Rural Care (SPARC) Act - S.1701/H.R.3503 NIH Clinical Trial Diversity Act of 2023 - H.R. 1114 Long COVID RECOVERY NOW Act - S.2840 the Bipartisan Primary Care and Health Workforce Act - Reducing Drug Prices for Seniors Act - Improving Seniors Timely Access to Care Act

Lobbyist	Covered position, as disclosed
ALISA VIDULICH CASAVANT New	Policy Director
CHARLES HUSSER New	Federal Affairs Manager
ANNA HYDE	Vice President, Advocacy and Access

Contacted: Food & Drug Administration (FDA); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2761 (118th), H.R. 4507 (118th), H.R. 1114 (118th), H.R. 824 (118th), H.R. 1770 (118th), H.R. 830 (118th), H.R. 3561 (118th), H.R. 4822 (118th), S. 1701 (118th), H.R. 2630 (118th), S. 2840 (118th), H.R. 3503 (118th), H.R. 5378 (118th), S. 1339 (118th), S. 127 (118th)

Budget/Appropriations BUD

FY24 Appropriations - PSLRP and CDRMP for Arthritis, NIH and CDC, improving osteoporosis care and awareness

Lobbyist	Covered position, as disclosed
ALISA VIDULICH CASAVANT New	Policy Director
CHARLES HUSSER New	Federal Affairs Manager
ANNA HYDE	Vice President, Advocacy and Access

Contacted: Labor, Dept of (DOL); SENATE; Natl Institutes of Health (NIH); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.